NYSEARCA:PGM iPath Series B Bloomberg Platinum Subindex Total Return ETN (PGM) Price, Holdings, & News $49.41 0.00 (0.00%) As of 06/14/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About iPath Series B Bloomberg Platinum Subindex Total Return ETN (NYSEARCA:PGM) Get PGM alerts:Sign Up Key Stats Today's Range$49.41▼$49.4150-Day Range$49.41▼$49.4152-Week Range$37.71▼$54.66VolumeN/AAverage Volume314 shsMarket Capitalization$5.44 millionAssets Under ManagementN/ADividend Yield0.00%Net Expense Ratio0.45%Aggregate RatingN/A ETF Overview Read More iPath Series B Bloomberg Platinum Subindex Total Return ETN ExpensesTypePGMPlatinum ETFsCommodities ETFsNYSEARCA ETFsAll ETFsManagement Fee0.00%0.60%0.70%0.51%0.53%Other Expenses0.00%0.50%0.32%0.58%0.55%Total Expense0.00%0.55%0.82%0.74%0.73%Fee Waiver0.00%0.00%-0.32%-0.70%-0.62%Net Expense0.45%0.52%0.70%0.58%0.60% Receive PGM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iPath Series B Bloomberg Platinum Subindex Total Return ETN and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PGM ETF News HeadlinesLifezone Produces First-Ever Platinum, Palladium and Rhodium from its U.S. PGM Recycling Project Lifezone's Simulus Laboratories Completes Locked-Cycle and Pilot Test WorkApril 7, 2026 | businesswire.comSibanye Stillwater: Lesser-Known PGM Play With A Turnaround ArcMarch 8, 2026 | seekingalpha.comStranded On The Flood Plains of HistoryThe petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar.June 20 at 1:00 AM | Porter & Company (Ad)iPath® Bloomberg Cocoa Subindex Total Return(SM) ETNJanuary 29, 2025 | in.investing.comJJG - iPath Series B Bloomberg Grains Subindex Total Return ETNAugust 7, 2023 | finance.yahoo.comETFs to Ride the Platinum RallyApril 24, 2023 | finance.yahoo.comSee More Headlines PGM ETF - Frequently Asked Questions How have PGM shares performed this year? iPath Series B Bloomberg Platinum Subindex Total Return ETN's stock was trading at $49.41 at the start of the year. Since then, PGM shares have increased by 0.0% and is now trading at $49.41. How do I buy shares of iPath Series B Bloomberg Platinum Subindex Total Return ETN? Shares of PGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of iPath Series B Bloomberg Platinum Subindex Total Return ETN own? Based on aggregate information from My MarketBeat watchlists, some other companies that iPath Series B Bloomberg Platinum Subindex Total Return ETN investors own include Pfizer (PFE), Seagen (SGEN), Zimmer Biomet (ZBH), CenterPoint Energy (CNP), Chevron (CVX) and Decision Diagnostics (DECN). Fund Details IssuerBarclays Capital Fund NameiPath Series B Bloomberg Platinum Subindex Total Return ETN Tax ClassificationExchange-Traded Note Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PGM Inception Date1/17/2018 Fund ManagerN/A Webwww.barclays.co.uk Phone442035554619Fund Focus Asset ClassCommodities BenchmarkBloomberg Platinum Subindex Total Return CategoryPrecious Metals FocusPlatinum Development LevelBlended Development RegionGlobal Number of Holdings0 Fund Statistics Assets Under Management$0.00 Average Daily Volume$811.00 Discount/Premium0.02% Administrator, Advisor and Custodian AdministratorN/A AdvisorN/A CustodianN/A DistributorN/A Transfer AgentN/A TrusteeN/A Lead Market MakerVirtu Financial Miscellaneous Outstanding Shares110,000BetaN/A 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free Report This page (NYSEARCA:PGM) was last updated on 6/20/2026 by MarketBeat.com Staff. From Our PartnersBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | SponsoredHow to play the Biggest IPO in stock market history!SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...InvestPub | SponsoredForget the million-dollar nest eggNearly 2 in 3 Americans fear running out of money more than death - and chasing a $1.5 million nest egg isn't ...Investors Alley | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredBofA: Digital Dollar Coming 2025-2030The US government has ONLY ONE mathematical escape from $38.4T in debt: explosive AI-driven GDP growth. AI ...Decentralized Masters | SponsoredRead this before you touch SPCXSPCX is live on Nasdaq - but a market expert who called AMD before it climbed as high as 7,100% says buying th...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iPath Series B Bloomberg Platinum Subindex Total Return ETN Please log in to your account or sign up in order to add this asset to your watchlist. Share iPath Series B Bloomberg Platinum Subindex Total Return ETN With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
